Blueprint Medicines Financial Statements Trends

BPMC -- USA Stock  

USD 66.14  0.84  1.25%

This module enables investors to look at Blueprint Medicines various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Interest Expense of 818.8 K, Operating Expenses of 74.2 M or Preferred Dividends Income Statement Impact of 3.7 M, but also many exotic indicators such as Long Term Debt to Equity of 0.0608, Revenue to Assets of 0.075 or Total Assets Per Share of 7.7762. This module is a perfect complement to use when analyzing Blueprint Medicines Valuation or Volatility. It can also complement various Blueprint Medicines Technical models. Check also analysis of Blueprint Medicines Correlation with competitors.

Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets178.9 M178.9 M66.2 M
Increasing
Slightly volatile
Cash and Equivalents607.3 M164.1 M96.9 M
Increasing
Slightly volatile
Deferred Revenue16 M13.6 M13.8 M
Increasing
Slightly volatile
Trade and Non Trade Receivables4 M3.4 M3.5 M
Increasing
Slightly volatile
Trade and Non Trade Payables2.9 M2.5 M1.7 M
Increasing
Slightly volatile
Total Liabilities41.1 M34.9 M49.5 M
Decreasing
Very volatile
Shareholders Equity169.4 M144 M19.3 M
Increasing
Slightly volatile
Accumulated Retained Earnings Deficit(158.8 M)(135 M)(78.3 M)
Decreasing
Slightly volatile
Current Assets170.4 M170.4 M62.3 M
Increasing
Slightly volatile
Assets Non Current10 M8.5 M4.1 M
Increasing
Slightly volatile
Current Liabilities18.6 M18.6 M8.6 M
Increasing
Slightly volatile
Liabilities Non Current19.2 M16.3 M40.6 M
Decreasing
Stable
Total Debt1.1 M7.3 M4.4 M
Increasing
Slightly volatile
Debt Current3.8 M3.3 M1.7 M
Increasing
Slightly volatile
Debt Non Current4.8 M4.1 M3.3 M
Increasing
Slightly volatile
Shareholders Equity USD169.4 M144 M19.3 M
Increasing
Slightly volatile
Cash and Equivalents USD193 M164.1 M62.3 M
Increasing
Slightly volatile
Total Debt USD8.6 M7.3 M5 M
Increasing
Slightly volatile

Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues16.5 M11.4 M11.8 M
Increasing
Slightly volatile
Research and Development Expense57.2 M48.6 M28.9 M
Increasing
Slightly volatile
Operating Expenses74.2 M63 M37.5 M
Increasing
Slightly volatile
Interest Expense818.8 K696 K360.5 K
Increasing
Slightly volatile
Consolidated Income(62.1 M)(52.8 M)(33.9 M)
Decreasing
Slightly volatile
Net Income(176.7 M)(52.8 M)(43.5 M)
Decreasing
Slightly volatile
Preferred Dividends Income Statement Impact3.7 M3.2 M3.3 M
Increasing
Slightly volatile
Net Income Common Stock(65.8 M)(55.9 M)(37.2 M)
Decreasing
Slightly volatile
Weighted Average Shares43.8 M18.2 M8.9 M
Increasing
Slightly volatile
Weighted Average Shares Diluted21.5 M18.2 M7.1 M
Increasing
Slightly volatile
Earning Before Interest and Taxes EBIT(61.3 M)(52.1 M)(33.6 M)
Decreasing
Slightly volatile
Revenues USD13.4 M11.4 M11.6 M
Increasing
Slightly volatile
Net Income Common Stock USD(65.8 M)(55.9 M)(37.2 M)
Decreasing
Slightly volatile
Earning Before Interest and Taxes USD(61.3 M)(52.1 M)(33.6 M)
Decreasing
Slightly volatile
Gross Profit(123.3 M)11.4 M178.3 K
Decreasing
Slightly volatile
Operating Income(60.8 M)(51.6 M)(33.5 M)
Decreasing
Slightly volatile

Cash Flow Statement

Trends Matrix
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditure(5.7 M)(4.9 M)(1.9 M)
Decreasing
Slightly volatile
Net Cash Flow from Financing180.3 M153.2 M70.6 M
Increasing
Slightly volatile
Issuance Repayment of Debt Securities (2.1 M)(1.8 M)1.6 M
Decreasing
Slightly volatile
Issuance Purchase of Equity Shares182.4 M155 M54 M
Increasing
Slightly volatile
Net Cash Flow from Investing(7.2 M)(6.1 M)(2.3 M)
Decreasing
Slightly volatile
Net Cash Flow from Operations(138.3 M)(31.7 M)(33.5 M)
Decreasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents135.8 M115.5 M43.2 M
Increasing
Slightly volatile
Share Based Compensation6.1 M5.2 M2.2 M
Increasing
Slightly volatile

Fundamental Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share(3.6118)(3.07)(17.4368)
Increasing
Slightly volatile
Earnings per Diluted Share(4.37)(3.07)(17.5)
Increasing
Slightly volatile
Earnings per Basic Share USD(3.6118)(3.07)(17.4368)
Increasing
Slightly volatile
Return on Average Equity(0.4655)(0.586)0.3227
Decreasing
Slightly volatile
Return on Average Assets(0.2478)(0.353)(1.2449)
Increasing
Slightly volatile
Return on Invested Capital(33.6012)(28.561)(18.183)
Decreasing
Slightly volatile
Gross Margin1.17651.01.0147
Increasing
Slightly volatile
Profit Margin(5.7706)(4.905)(4.9771)
Decreasing
Slightly volatile
EBITDA Margin(5.2765)(4.485)(4.551)
Decreasing
Slightly volatile
Return on Sales(5.3741)(4.568)(4.6352)
Decreasing
Slightly volatile
Asset Turnover0.08470.0720.0731
Increasing
Slightly volatile
Enterprise Value over EBITDA(12.4376)(10.572)(10.7275)
Decreasing
Slightly volatile
Enterprise Value over EBIT(11.7647)(10.0)(10.1471)
Decreasing
Slightly volatile
Price to Earnings Ratio(22.46)(8.58)(9.7367)
Decreasing
Slightly volatile
Sales per Share0.73530.6250.6342
Increasing
Slightly volatile
Price to Sales Ratio17842.13553.4171
Increasing
Slightly volatile
Price to Book Value5.144.9584.9732
Increasing
Slightly volatile
Debt to Equity Ratio0.10.243(0.7083)
Increasing
Slightly volatile
Current Ratio15.399.1424.6154
Increasing
Slightly volatile
Free Cash Flow per Share13.85(2.005)(12.5457)
Increasing
Slightly volatile
Book Value per Share9.28827.895(25.287)
Increasing
Slightly volatile
Tangible Assets Book Value per Share11.54129.818.439
Increasing
Slightly volatile
Total Assets Per Share7.77626.60986.833
Increasing
Stable
Cash Flow Per Share(1.3769)(1.1703)(11.3075)
Increasing
Slightly volatile
Long Term Debt to Equity0.06080.05170.1561
Decreasing
Slightly volatile
Quick Ratio10.00178.50146.106
Increasing
Slightly volatile
Net Current Assets as percentage of Total Assets99.811184.839426.5106
Increasing
Slightly volatile
Revenue to Assets0.0750.06370.0647
Increasing
Slightly volatile

Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings before Tax(62.1 M)(52.8 M)(33.9 M)
Decreasing
Slightly volatile
Market Capitalization2.9 B713.8 M899.3 M
Increasing
Slightly volatile
Enterprise Value2.3 B540.5 M690.4 M
Increasing
Slightly volatile
Invested Capital30.2 M53.8 M15 M
Increasing
Slightly volatile
Average Equity112.2 M95.4 M(7.1 M)
Increasing
Slightly volatile
Average Assets186.6 M158.6 M73.2 M
Increasing
Slightly volatile
Invested Capital Average2.1 M1.8 M2.8 M
Decreasing
Slightly volatile
Tangible Asset Value210.5 M178.9 M68.8 M
Increasing
Slightly volatile
Free Cash Flow(43 M)(36.6 M)(27 M)
Decreasing
Slightly volatile
Working Capital151.8 M151.8 M53.6 M
Increasing
Slightly volatile
Revenue Per Employee165.6 K140.7 K142.8 K
Increasing
Slightly volatile
Net Income Per Employee(766.4 K)(651.5 K)(674.3 K)
Decreasing
Stable

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Blueprint Medicines Upcoming Company Events

Upcoming Quarterly ReportMarch 10, 2017
Next Earnings ReportMay 9, 2017
Check also analysis of Blueprint Medicines Correlation with competitors. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.